Sign in
Taking people in United StatesNo phase

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Key facts

Who runs it
Children's Hospital Medical Center, Cincinnati
Where
Chicago, Cincinnati, Columbus, Dallas, Indianapolis, Palo Alto, Pittsburgh, Seattle, and St Louis, United StatesSee the 9 sites
Trial code
Status
Recruiting
People taking part
800 people, planned
Started
28 Apr 2022
Expected to end
30 Jun 2033
Type of study
Observational
Treatments tested
  • No interventions
Record updated
16 November 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Clinical diagnosis of autoimmune hepatitis (AIH)
  • Clinical diagnosis of primary sclerosing cholangitis (PSC)
  • Clinical diagnosis of autoimmune sclerosing cholangitis (ASC)

Who cannot take part

  • History of liver transplant

This trial is currently available in United States.

  • Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, United StatesContact: Melissa Espinosa Research Coordinator, BSTaking people
  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: Cyd M Castro-Rojas, PhDTaking people
  • Nationwide Children's HospitalColumbus, United StatesContact: Aishwarya R. Keesara, BDS, MSTaking people
  • UT Southwestern Medical CenterDallas, United StatesContact: Chelsea D Pratt, MSTaking people
  • Riley Children's HealthIndianapolis, United StatesContact: Wendy Morlan, RN, BSNTaking people
  • Stanford UniversityPalo Alto, United StatesContact: Yael Bichman, BSTaking people
  • UPMC Children's Hospital of PittsburghPittsburgh, United StatesContact: Laura Mathews, Research Coordinator, BSTaking people
  • Seattle Children's HospitalSeattle, United StatesContact: Chelsea S Caranto, BSTaking people
  • St. Louis Children's HospitalSt Louis, United StatesContact: Kenyetta Shelby, BSTaking people

About the trial

What the trial wants to find out

The Autoimmune Liver disease Network for Kids (A-LiNK) is a multi-institutional group with the mission to deliver the best care to kids with pediatric autoimmune liver disease (AILD).

Read full original descriptionShow less

This study will establish a shared clinical registry and a learning health network for the participating sites focusing on collecting and transmitting clinical measurement data, information about processes, and participation in an improvement collaborative.

Pediatric Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC), represent a spectrum of AILD which present unique diagnostic and therapeutic challenges.A lack of accepted guidelines for disease monitoring or symptom management results in wide treatment variation with liver transplants indicated in refractory, progressive disease.

The aims of A-LiNK are to:

1.) Create a learning health network focused on patient-centered outcomes research characterized by transparent sharing among centers, common priorities, and feasible plans for implementing new practices; 2) shift from traditional investigator-driven study to a patient and family-centered approach, and 3.) improve clinical outcomes and quality of life for pediatric AILD patients.

The group in the trial

  • Children and adolescents with Autoimmune Liver Disease

    Pediatric patients with a diagnosis of autoimmune hepatitis, or primary sclerosing cholangitis.

    Treatment: No interventions

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Autoimmune Liver Disease Network for Kids (A-LiNK): Using Patient Data to Transform Care and Improve Outcomes for Children, Adolescents, and Young Adults With Autoimmune Liver Disease
Record updated
16 November 2026